Trials / Completed
CompletedNCT01427712
Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 1 Year – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at collecting the information related to the safety and effectiveness in the pancreatic exocrine insufficiency patients due to cystic fibrosis receiving the treatment with LipaCreon in order to evaluate the effective and safe use of LipaCreon.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pancrelipase |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2011-09-02
- Last updated
- 2022-06-10
- Results posted
- 2022-06-10
Locations
21 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01427712. Inclusion in this directory is not an endorsement.